Analyst Ratings for Bristol-Myers Squibb Co. (BMY)
BMY Rating Summary
BMY Price Target Summary
- Highest: $90.00 (Citi)
- Lowest: $40.00 (Morgan Stanley)
- Average: $59.45
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$59.45 (+23.1%)
* Over Last 12-Mos
Rating Score: 1.7 / 10
Percentile Rank: 12%
Rating Score: 1.7 / 10
Percentile Rank: 12%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/11/2024 | Societe Generale | Justin Smith | Downgrade | Hold (Buy) |
51.00 (85.00) |
53.79 (48.30) |
-10.21% | Details |
| 2/6/2024 | Redburn-Atlantic | Steve Chesney | Downgrade | Neutral (Buy) |
54.00 (77.00) |
48.71 (48.30) |
-0.84% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
